Đang chuẩn bị liên kết để tải về tài liệu:
Respective effects of phlebotomy losses and erythropoietin treatment on the need for blood transfusion in very premature infants

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG Tải xuống

The benefit to risk ratio of the treatment with erythropoietin (EPO) as a means of limiting the number of transfusions in very preterm infants during hospitalization, seems to be modest since the adoption of restrictive transfusion criteria and of policy limiting phlebotomy losses. | Respective effects of phlebotomy losses and erythropoietin treatment on the need for blood transfusion in very premature infants